27 Amendments of Gaston FRANCO related to 2011/0402(CNS)
Amendment 159 #
Proposal for a decision
Recital 1 a (new)
Recital 1 a (new)
(1a) Widening participation should be encouraged in order to exploit the potential of Europe's talent pool and to optimise the economic and social impact of research, something that should contribute to closing the research and innovation gap in Europe, using agents such as science centres and museums in engaging high numbers and a wide range of audiences and citizens.
Amendment 178 #
Proposal for a decision
Recital 11 a (new)
Recital 11 a (new)
(11 a) International cooperation is essential to achieve the stated aims of all parts of the specific programme, and international cooperation projects targeted at countries or groups of countries on horizontal or priority issues should be implemented under each part.
Amendment 188 #
Proposal for a decision
Article 3 – paragraph 1 – subparagraph 1 – point c
Article 3 – paragraph 1 – subparagraph 1 – point c
(c) strengthening skills, training and career development, through the Marie Skłodowska-Curie actions (‘Marie Curie actions’);. Science centres and museums have proven their expertise in training young scientists in science communication, working in close association with science research institutions and universities.
Amendment 268 #
Proposal for a decision
Annex 1 – point 1 – point 1.1 – paragraph 3
Annex 1 – point 1 – point 1.1 – paragraph 3
Particular attention will be paid to ensuring a broad approach to innovation, which is not only limited to the development of new products and services on the basis of scientific and technological breakthroughs, but which also incorporates aspects such as the use of existing technologies in novel applications, continuous improvement, non-technological and social innovation. Only a holistic approach to innovation can at the same time tackle societal challenges and give rise to new competitive businesses and industries. , social, cultural and institutional innovation. Innovation in services will also be encouraged by investing in multi-disciplinary competences, creation of capabilities, knowledge and value based on service solutions and intangible contents. Only a holistic approach to innovation can at the same time tackle societal challenges and give rise to new competitive businesses and industries. Science centres, museums and associations dedicated to education and public engagement of science through cultural activities can contribute to the achievement of these priorities, particularly regarding the societal challenges.
Amendment 279 #
Proposal for a decision
Annex 1 – point 1 – point 1.1 – paragraph 5
Annex 1 – point 1 – point 1.1 – paragraph 5
Detailed priority setting during implementation of Horizon 2020 will entail a strategic approach to programming of research, using modes of governance aligning closely with policy development yet cutting across the boundaries of traditional sectoral policies. This will be based on sound evidence, analysis and foresight, with progress measured against a robust set of performance indicators. This cross-cutting approach to programming and governance will allow effective coordination between all of Horizon 2020‘s specific objectives and will allow to address challenges which cut across them, such as for instance sustainability, climate change or marine sciences and technologies. Attention has to be put on the interrelations between education research and society in order to encourage vocations in science and technology and promote excellence. Involving the rising generation via youth think tanks, debates, promotion of scientific and technical careers, competitions to foster creativity and innovation in pedagogy.
Amendment 335 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – introductory part
Annex 1 – point 2 – paragraph 2 – introductory part
The focus of international cooperation in Horizon 2020 will be on cooperation with three major country groupings: industrialised and emerging economies, enlargement and neighbourhood countries and developing countries.
Amendment 336 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – point 1
Annex 1 – point 2 – paragraph 2 – point 1
Amendment 338 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – point 2
Annex 1 – point 2 – paragraph 2 – point 2
Amendment 341 #
Proposal for a decision
Annex 1 – point 2 – paragraph 2 – point 3
Annex 1 – point 2 – paragraph 2 – point 3
Amendment 342 #
Proposal for a decision
Annex 1 – point 2 – paragraph 3
Annex 1 – point 2 – paragraph 3
Amendment 348 #
Proposal for a decision
Annex 1 – point 2 – paragraph 5
Annex 1 – point 2 – paragraph 5
Amendment 350 #
Proposal for a decision
Annex 1 – point 2 – paragraph 6 – point a
Annex 1 – point 2 – paragraph 6 – point a
(a) The continuation and strengthening of the European and Developing Countries Clinical Trials Partnership (EDCTP2) on clinical trials for medical interventions against HIV, malaria and tuberculosis;
Amendment 360 #
Proposal for a decision
Annex 1 – point 3 – paragraph 4
Annex 1 – point 3 – paragraph 4
Cross-cutting action will also be vital in stimulating the interactions between the societal challenges and the enabling and industrial technologies needed to generate major technological breakthroughs. Examples of where such interactions may be developed are: the domain of eHealth, smart grids, intelligent transport systems, mainstreaming of climate actions, nanomedicine, testing methods that are more predictive and more relevant to human beings, risk assessment, medical research, advanced materials for lightweight vehicles or the development of bio-based industrial processes and products. Strong synergies will therefore be fostered between the societal challenges and the development of generic enabling and industrial technologies. This will be explicitly taken into account in developing the multi-annual strategies and the priority setting for each of these specific objectives. It will require that stakeholders representing the different perspectives are fully involved in the implementation and in many cases, it will also require actions which bring together funding from the enabling and industrial technologies and the societal challenges concerned.
Amendment 371 #
Proposal for a decision
Annex 1 – point 4 – paragraph 3
Annex 1 – point 4 – paragraph 3
Existing public-public and public-private partnerships may receive support from Horizon 2020, provided they address Horizon 2020 objectives, they meet the criteria laid down in Horizon 2020 and they have shown to make significant progress under the Seventh Framework Programme for Research, Technological Development and Demonstration (FP7). Science centres and museums who implement public-private, partnership with science institutions, companies, associations and citizens may also receive support from Horizon 2020 as they address key societal challenges in link with Horizon 2020 strategy.
Amendment 424 #
Proposal for a decision
Annex 1 – section 1 – point 3 – point 3.3 – paragraph 2
Annex 1 – section 1 – point 3 – point 3.3 – paragraph 2
European funding will support short term exchanges of research and innovation staff within partnerships of universities, research institutions, businesses, SMEs and other socio-economic actors among Europe, as well as between Europe and third countries to reinforce international cooperation. Specific measures will be taken with a view to strengthening the research capacities of developing countries. It will be open to research and innovation staff at all career levels, from the most junior (post-graduate) to the most senior (management), including also administrative and technical staff.
Amendment 469 #
Proposal for a decision
Annex 1 – section 2 – point 1 – paragraph 12 – indent 3 a (new)
Annex 1 – section 2 – point 1 – paragraph 12 – indent 3 a (new)
- the development and use of testing methods which are more predictive and relevant to the realities of human life, risk assessment and medical research
Amendment 604 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.1 – paragraph 2
Annex 1 – section 3 – point 1 – point 1.1 – paragraph 2
In particular, a better understanding of the environment as a determinant of health will require human-centred integrated molecular biological, epidemiological and toxicological approaches to investigate health- environment relationships and to elucidate the underlying mechanisms of illnesses and human toxicity, including studies of modes of action of chemicals, combined exposures to pollution and other environmental and climate related stressors, integrated toxicological testing as well as alternatives to animal testing. Innovative approaches to exposure assessment are needed using new- generation human-centred biomarkers based on 'omics' and epigenetics, human biomonitoring, personal exposure assessments and modelling to understand combined, cumulative and emerging exposures, integrating socio-economic and behavioural factors. Improved links with environmental data using advanced information systems will be supported.
Amendment 610 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.3 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.3 – paragraph 1
Human populations are under threat from new and emerging infections (including those resulting from climate change), from drug resistance to existing pathogens and from other direct and indirect consequences of climate change. Improved methods for surveillance, early warning networks, health service organisation and preparedness campaigns are needed for the modelling of epidemics, for effective pandemic response, for responses to non infectious disease consequences of climate change, as are efforts to maintain and enhance capabilities to combat drug resistant infectious disease. In order to face up to these global challenges, the EU will, in partnership with the countries concerned, implement measures aimed at achieving concrete results in health policy, improving health care services and supporting their own research capacity.
Amendment 616 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.5 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.5 – paragraph 1
There is a need for more effective preventive vaccines (or alternative preventive interventions) and evidence- based vaccination schemes for an expanded range of diseases. This relies on a better understanding of disease and disease processes and their consequent epidemics, more predictive, effective pre-clinical safety assessments (such as coherent approaches combined with other, non- animal or reductive approaches), and that clinical trials and associated studies are undertaken.
Amendment 620 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
An improved understanding of health, disease and disease processes at all ages is needed to develop new and more effective diagnostics. Innovative and existing technologies will be developed with the goal of significantly improving disease outcomes throughso that they can be adapted to different environmental and socio-economic conditions, with the goal of ensuring earlier, more accurate diagnosis and by allowing for more patient- adapted treatment.
Amendment 659 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.16 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.16 – paragraph 1
Support provided will cover the full spectrum of activities from capacity- building, knowledge and technology transfer to large (including health policy), implementation, monitoring and assessment of large-scale demonstration actions, leading to scalable solutions for European and beyond.
Amendment 899 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 1
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 1
– Linking in a competition emerging institutions, centres of excellence and innovative regions in less developed Member Statecities and regions to international leading counterparts elsewhere in Europe. This will involve teaming of excellent research institutions and less developed regions, twinning of staff exchanges, expert advice and assistance and the development of joint strategies for the establishment of centres of excellence that may be supported by the Cohesion policy funds in less developed and through Horizon 2020 in transition and competitive regions. Building links with innovative clusters and recognising excellence in less developed regions and developing regions, including through peer reviews and awarding labels of excellence to those institutions that meet international standards, will be considered.
Amendment 902 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 2
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 2
– Establishing ‘ERA Chairs’ to attract outstanding academics to institutions with a clear potential for research excellence, in order to help these institutions fully unlock this potential and hereby create a level playing field for research and innovation in the European Research Area. This will include institutional and regional support for creating a competitive research environment and the framework conditions necessary for attracting, retaining and developing top research talent within these institutions and embedding these institutions into regional innovation ecosystems.
Amendment 906 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 4
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 4
– Supporting the development and monitoring of smart specialisation strategies. A policy support facility will be developed and policy learning atin regional levels and cities will be facilitated through international evaluation by peers and best practice sharing.
Amendment 907 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 4 a (new)
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 4 a (new)
– Supporting regions and cities that share similar smart specialisations to network together to develop internationally competitive value chains.
Amendment 911 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 4 b (new)
Annex 1 – section 3 – point 6 – point 6.1 – point 6.1.4 – indent 4 b (new)
– Supporting the development of networks of triple helix partnerships within regions that can work together to coordinate the above actions of twinning, the exchange of best practice, embedding 'ERA Chairs' into the regional research and innovation system, supporting international networks linked to identified regional competences and the exchange of best practice on smart specialisation strategies.
Amendment 925 #
Proposal for a decision
Annex 1 – section 3 – point 6 – point 6.2 – point 6.2.3 – paragraph 1
Annex 1 – section 3 – point 6 – point 6.2 – point 6.2.3 – paragraph 1